The former head of the University of Minnesota's psychiatry department has complied with a request that he resign from another medical post, MPR News reports.
Dr. Charles Schulz will no longer be working on integrating the U of M's medical operations with Fairview Health Services, which owns the hospital where its students train, MPR says.
Schulz has been at the center of complaints that the U of M failed to adequately protect patients enrolled in tests of psychiatric drugs.
Under particular scrutiny is the 2004 suicide of Dan Markingson, while he was enrolled in a drug trial. The New York Times chronicled that case last month, prompting U of M president Eric Kaler to issue a rebuttal defending the university's reputation while also promising changes in medical research involving human subjects.
Kaler suspended enrollments in psychiatric drug studies after a report from Minnesota's legislative auditor cited ethical concerns.
He also put together an "implementation team" to recommend how to carry out changes suggested in the auditor's report.
That team says it will have a draft work plan posted on its website Monday and will take public comments on it until June 1.